Arcutis Biotherapeutics, Inc. Research And Development Expense

Quick Answer

Arcutis Biotherapeutics, Inc. reported Research And Development Expense of $77.05 million for the year ending 2025.

  • Arcutis Biotherapeutics, Inc. showed an increase of +0.8% in Research And Development Expense from 2024 to 2025.
  • This data is from Arcutis Biotherapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2018 to 2025), Arcutis Biotherapeutics, Inc.'s Research And Development Expense has grown by 329.5%.
  • Historical annual values: Fiscal year 2025: $77.05 million | Fiscal year 2024: $76.42 million | Fiscal year 2023: $110.58 million | Fiscal year 2022: $182.44 million | Fiscal year 2021: $145.56 million | Fiscal year 2020: $115.31 million | Fiscal year 2019: $36.52 million | Fiscal year 2018: $17.94 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: